Kenya recalls Johnson & Johnson children's cough syrup over suspected toxicity
Thursday April 11 2024
The Johnson & Johnson logo is displayed on a screen on the floor of the New York Stock Exchange (NYSE) in New York, US on May 29, 2019. PHOTO | REUTERS
Kenya's drug regulator is recalling a batch of Johnson & Johnson children's cough syrup, it said on Thursday, a day after Nigeria recalled the same batch of medication under the Benylin Paediatric brand.
Nigeria's health regulator said laboratory tests on the syrup showed a high level of diethylene glycol, which has been linked to the deaths of dozens of children in Gambia, Uzbekistan and Cameroon since 2022 in one of the world's worst waves of poisoning from oral medication.
Kenya's Pharmacy and Poisons Board (PPB) said in a statement it had commenced investigations and advised that sales of certain batches of the product be halted and returned to suppliers.
Read: Kenya recalls children drug over safety concerns
Kenvue, which now owns the Benylin brand after a spin-off from J&J last year, did not immediately respond to a request for comment.
The batch being recalled was made by J&J in South Africa in May 2021 with an expiration date of April 2024, PPD said.